非侵入性耳部针刺激改善缓慢过渡性便秘:来自随机对照试验的证据
概括
与普鲁卡洛普里德相结合的非侵入性耳部针刺激显著改善了慢过渡性便秘症状. 这种方法为有效管理便秘提供了一个有前途的补充疗法.
科学领域:
- 胃肠病学 胃肠病学
- 神经调节是一种神经调节.
- 补充医学是一种补充医学.
背景情况:
- 慢过渡性便秘 (STC) 缺乏有效的治疗方法,原因是目前治疗方法的副作用和有效性有限.
- 耳部针点刺激 (AAS) 是STC的潜在神经调节辅助方法,但其临床实用性尚未得到证实.
研究的目的:
- 评估非侵入性耳部针点刺激 (AAS) 作为普鲁卡洛普里德治疗慢过渡性便秘 (STC) 的补充剂的疗效.
- 调查AAS在调节胃肠功能和STC患者的症状评分中的机制性作用.
主要方法:
- 60名STC患者 (40-75岁) 被随机分为两组:研究 (AAS + 普鲁卡洛普里德) 和控制 (普鲁卡洛普里德单一治疗).
- 干预措施通过监测血清神经Y (NPY),氧化 (NO),便中的水含量和胃肠道传输时间来评估.
- 症状得分被用来确定治疗结果的比较.
主要成果:
- 研究小组的整体疗效率 (93.3%) 与对照组 (84.6%,P<0.05) 相比显著提高.
- 两组都显示了NPY和NO水平的降低,便水含量增加和结肠过境.
- 与对照组相比,AAS组在NPY/NO中表现出更显著的减少,在运输和水含量方面有更大的改善 (P<0.05).
结论:
- 无创性耳部针点刺激显著提高缓慢过渡便秘患者的症状缓解.
- AAS显示出作为有效的便秘管理补充疗法的潜力,改善胃肠功能标志物.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
111
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
111
Drugs for Treatment of Diarrhea-Predominant IBS
124
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
124


